title: Seven years' experience with Integra as a reconstructive tool.
abstract: The bilayered dermal substitute Integra (Integra Life Sciences Corp., Plainsboro, NJ) was developed and has been widely used as primary coverage for excised acute burns. Our take has been slightly different, finding it most useful in the management of complex soft-tissue loss and threatened extremities as the result of tendon, joint, or bone exposure. Often tasked to fill significant volume loss, we have become adept at stacked multiple-layer applications. Creative use of this material has resulted in unexpected successes with distal limb salvage; the technique takes its place beside adjacent tissue transfer, composite flaps, and vascular pedicle flaps in our burn reconstructive practice. A prospective registry (44 patients) has been kept during the past 7 years that catalogs wounds with complex soft-tissue loss treated with Integra grafts. Many of these patients were at risk of extremity loss because of exposed tendons, joints, or bone. Integra was applied after 1:1 meshing. With profound soft-tissue defects, multiple layers of Integra were serially applied 1 to 2 weeks apart for reconstitution of soft-tissue contours. Local Integra graft infections were managed by silicone unroofing followed by topical sulfamylon liquid dressings. Wounds addressed included fourth-degree burns, necrotizing fasciitis, pit-viper envenomations, and total abdominal wall avulsion in one patient after being run over by a bus. Patients generally were free of pain from their wounds during the maturation phase of the Integra neodermis. Restoration of tissue contour was significantly better when using multiple layers for deep defects. Second and third layers of Integra were successfully applied after an abbreviated first graft maturation period of 7 days. Epithelial autografts on multilayer Integra applications frequently "ghosted"; they would auto-digest to dispersed cells followed subsequently by the reappearance of a confluent epithelial layer. Final grafted skin morphology over palmar and plantar surfaces assumed the type and fingerprint pattern of the original tissues. Infections were readily visible. Early recognition kept them to easily treated circumscribed areas, which did not jeopardize the entire wound. Lengths of stay were long (range, 2-246 days) but not significantly greater than with traditional techniques. The specific reconstructive use of Integra permitted unexpected salvage of several threatened extremities by protecting exposed tendons, bones and joints. Long-term histologic examination revealed unexpected persistence of Integra collagen. Large volume loss wounds benefited from the ability to fill voids with multilayered applications.
authors.affiliation: The Burn Center at Washington Hospital Center, Washington, DC 20010, USA.
authors.forename: James C
authors.initials: JC
authors.lastname: Jeng
authors.forename: Philip E
authors.initials: PE
authors.lastname: Fidler
authors.forename: Julio C
authors.initials: JC
authors.lastname: Sokolich
authors.forename: Amin D
authors.initials: AD
authors.lastname: Jaskille
authors.forename: Shaher
authors.initials: S
authors.lastname: Khan
authors.forename: Patricia M
authors.initials: PM
authors.lastname: White
authors.forename: James H
authors.initials: JH
authors.lastname: Street
authors.forename: Timothy D
authors.initials: TD
authors.lastname: Light
authors.forename: Marion H
authors.initials: MH
authors.lastname: Jordan
mesh_terms: D000007:Abdominal Injuries / Q000601:surgery; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000671:Amputation, Surgical / Q000706:statistics & numerical data; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D001458:Bandages; D002056:Burns / Q000601:surgery*; D016022:Case-Control Studies; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D003094:Collagen / Q000627:therapeutic use*; D019115:Fasciitis, Necrotizing / Q000601:surgery; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data; D008272:Mafenide / Q000627:therapeutic use; D008875:Middle Aged; D011091:Polyesters / Q000627:therapeutic use; D011095:Polyethylenes / Q000627:therapeutic use; D011446:Prospective Studies; D012042:Registries; D016038:Skin Transplantation; D017768:Skin, Artificial; D012909:Snake Bites / Q000601:surgery; D013530:Surgical Wound Infection / Q000628:therapy; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: C117408:Acticoat; D000891:Anti-Infective Agents, Local; D011091:Polyesters; D011095:Polyethylenes; C114835:integra artificial skin; D008272:Mafenide; D002809:Chondroitin Sulfates; D003094:Collagen